Allyl isothiocyanate suppressed periodontal tissue destruction in mice via bacteriostatic and anti-inflammatory activities against Porphyromonas gingivalis

Arch Oral Biol. 2025 Jan:169:106118. doi: 10.1016/j.archoralbio.2024.106118. Epub 2024 Oct 23.

Abstract

Objectives: Allyl isothiocyanate (AITC) is a phytochemical that is abundantly present in cruciferous vegetables, such as wasabi and mustard. Among its pharmacological properties, it demonstrates anticancer, antifungal, and anti-inflammatory activities. This study aimed to investigate the functions of AITC against periodontopathic bacteria and its effects on a mouse model of periodontitis.

Design: The antimicrobial and antibiofilm functions of AITC were assessed against Porphyromonas gingivalis, Fusobacterium nucleatum, and Streptococcus mitis. To clarify its anti-inflammatory effects, macrophage-like cells from THP-1 were stimulated with P. gingivalis lipopolysaccharide (LPS), and the release of inflammatory cytokines was analyzed by ELISA. Experimental periodontitis was induced in 9-week-old mice by ligation and oral infection of P. gingivalis, and AITC was injected into the gingiva once daily for 8 days. Alveolar bone resorption was evaluated by measuring the exposed root area. Gene expressions in the periodontal tissue were analyzed via qPCR.

Results: AITC exerted weak bacteriostatic effects against P. gingivalis, inhibiting biofilm formation. AITC also impeded the production of interleukin-6 and tumor necrosis factor-α induced by P. gingivalis LPS. Additionally, transient receptor potential ankyrin 1(TRPA1) channel agonist inhibited the anti-inflammatory effects of AITC. In vivo, AITC inhibited alveolar bone destruction and decreased the gene transcription of Il6 in the periodontal tissue.

Conclusion: AITC exerted weak bacteriostatic and anti-inflammatory effects against P. gingivalis, reducing alveolar bone destruction and suppressing the inflammatory response in experimental periodontitis. Therefore, AITC may serve as a valuable adjunct in controlling periodontal disease.

Keywords: Allyl isothiocyanate; Anti-inflammation; Bacteriostatic activity; Periodontitis.

MeSH terms

  • Alveolar Bone Loss / drug therapy
  • Alveolar Bone Loss / prevention & control
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Inflammatory Agents* / pharmacology
  • Biofilms* / drug effects
  • Cytokines / metabolism
  • Disease Models, Animal*
  • Enzyme-Linked Immunosorbent Assay
  • Fusobacterium nucleatum* / drug effects
  • Interleukin-6 / metabolism
  • Isothiocyanates* / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects
  • Male
  • Mice
  • Periodontitis / drug therapy
  • Periodontitis / microbiology
  • Porphyromonas gingivalis* / drug effects
  • Streptococcus mitis / drug effects
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Isothiocyanates
  • allyl isothiocyanate
  • Anti-Inflammatory Agents
  • Lipopolysaccharides
  • Anti-Bacterial Agents
  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Interleukin-6